Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PROCEPT BioRobotics Corporation Common Stock
PRCT | US
25.12
USD-0.24
-0.95%
PRCT | US
About PROCEPT BioRobotics Corporation Common Stock
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
02/04/2026
Close
25.12
Open
24.92
High
26.04
Low
24.50
PROCEPT BioRobotics Corporation a surgical robotics company develops transformative solutions in urology. It develops manufactures and sells AquaBeam Robotic System an image-guided surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City California.
View LessPRCT | US
Risk
72.0
Sharpe
-1.04
Luna's Score
45/100
Recommendation
Sell
Luna says (PRCT | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
38.8%1 month
72.0%3 months
70.7%6 months
63.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
14.22
Debt to equity
0.32
Debt to assets
0.22
Ent. to EBITDA
-24.58
Ent. to rev.
19.53
PEG
-
Other Fundamentals
EBITDA
-104.82M
MarketCap
1.30B
MarketCap(USD)
1.30B
Div. yield
-
Op. margin
-50.28
Erngs. growth
-
Rev. growth
61.20
Ret. on equity
-50.88
Short ratio
9.60
Short perc.
14.58
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.98
Range1M
5.89
Range3M
16.05
Volumes: Market Activity
Rel. volume
0.50
Price X volume
20.07M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -24.58 | - | Cheaper |
| Ent. to Revenue | 19.53 | - | Expensive |
| PE Ratio | - | 30.41 | - |
| Price to Book | 14.22 | 6.21 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 70.72 | - | Par |
| Debt to Equity | 0.32 | -145.53 | Expensive |
| Debt to Assets | 0.22 | 0.35 | Cheaper |
| Market Cap | 1.30B | - | Emerging |
